Elevance Health Share Price Today
(NASDAQ: ELV)

Name: Elevance Health Share Price Today (NASDAQ: ELV) - Elevance Health Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Elevance Health share price is $452.69 & ₹38,692.55 as on 5 Apr 2025, 2.30 'hrs' IST

$452.69

▲

23.36

(5.44%)

Market is closed - opens 7 PM, 04 Apr 2025

View live Elevance Health share price in Dollar and Rupees. Guide to invest in Elevance Health stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Elevance Health, along with analyst recommendations, forecasts, and comprehensive financials.

Elevance Health share price movements

Today's Low: $434.93
Today's High: $454.24
$452.69
3.92%
Downside
Day's Volatility :4.25%
Upside
0.34%
52 Weeks Low: $362.21
52 Weeks High: $567.26
$452.69
19.99%
Downside
52 Weeks Volatility :36.15%
Upside
20.2%

Elevance Health (ELV) Returns

Period	Elevance Health, Inc	Sector (Health Care)	S&P500
3 Months	16.45%	3.2%	-4.6%
6 Months	-12.07%	-5.4%	-0.5%
1 Year	-13.22%	-0.5%	8.8%
3 Years	-12.55%	3.8%	24.8%

Elevance Health (ELV) Key Statistics

in dollars & INR

Previous Close	$429.33
Open	$430.15
Today's High	$454.24
Today's Low	$434.93
Market Capitalization	$98.0B
Today's Volume	$1.2M
52 Week High	$567.26
52 Week Low	$362.21
Revenue TTM	$176.8B
EBITDA	$9.9B
Earnings Per Share (EPS)	$25.7
PE Ratio	16.84
Dividend Yield	1.58%
Profit Margin	3.38%
Quarterly Earnings Growth YOY	-0.5%
Return On Equity TTM	14.77%

How to invest in Elevance Health Stock (ELV) from India?

It is very easy for Indian residents to invest directly in Elevance Health from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Elevance Health stock in both Indian Rupees (INR) and US Dollars (USD). Search for Elevance Health or ELV on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Elevance Health or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Elevance Health shares which would translate to 0.002 fractional shares of Elevance Health as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Elevance Health, in just a few clicks!

Returns in Elevance Health (ELV) for Indian investors in Rupees

The Elevance Health stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Elevance Health investment value today

Current value as on today

₹93,224

Returns

₹6,776

(-6.78%)

Returns from Elevance Health Stock

₹9,208 (-9.21%)

Dollar Returns

₹2,432 (+2.43%)

Indian investors sentiment towards Elevance Health (ELV)

-15.91%

Period: Mar 4, 2025 to Apr 3, 2025. Change in 30 Days versus previous period

Investment in Elevance Health Shares from India has dropped by -15.91% over the past 30 days, indicating reduced transactional activity.

Period: Mar 4, 2025 to Apr 3, 2025. Change in 30 Days versus previous period

Search interest for Elevance Health Stock from India on INDmoney has increased by 0% in the last 30 days, reflecting an upward trend in search activity.

Indian Mutual Funds that invest in Elevance Health Stock (ELV Ticker)

Name	Shares Held	Change in Shares	% of Assets
Nippon India US Equity Opportunities Fund Direct Growth	7071	-1622.09	3.38%
Motilal Oswal S&P 500 Index Fund Direct Growth	2001	7.94	0.18%

Global Institutional Holdings in Elevance Health

Vanguard Group Inc
9.45%
BlackRock Inc
8.99%
State Street Corp
4.70%
T. Rowe Price Associates, Inc.
4.67%
Wellington Management Company LLP
2.80%
Geode Capital Management, LLC
2.18%

Analyst Recommendation on Elevance Health

Buy

84%Buy

15%Hold

0%Sell

Based on 26 Wall street analysts offering stock ratings for Elevance Health(by analysts ranked 0 to 5 stars)

Based on 26 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Elevance Health Stock (ELV)

What analysts predicted

Upside of 10.05%

Target:

$498.18

Current:

$452.69

Insights on Elevance Health Stock (Ticker Symbol: ELV)

Price Movement
In the last 1 month, ELV stock has moved up by 9.4%
Increasing Revenue
Elevance Health, Inc. has shown consistent growth in revenue over the past four quarters. The revenue increased from $42.57 billion to $45.44 billion, marking an average rise of 2.1% each quarter.
Decreasing Net Profit
Elevance Health, Inc. has experienced a decline in net profit over the last three quarters. The net profit dropped from $2.3 billion to $418 million, leading to an average decrease of 57.3% each quarter.
ELV vs UNH (1 yr)
In the last 1 year, Unitedhealth Group Incorporated has given 13.8% return, outperforming this stock by 28.3%
ELV vs CI (3 yr)
In the last 3 years, The Cigna Corp has given 2.1% return, outperforming this stock by 15.4%
Price to Sales
Elevance Health, Inc. has a Price-to-Sales Ratio of 0.6, meaning that investors are willing to pay $0.60 for every $1 of sales the company generates. In comparison, UnitedHealth Group Incorporated has a higher Price-to-Sales Ratio of 1.2, where investors pay $1.20 for every $1 of sales. This indicates that investors value Elevance Health less per sales dollar than they do UnitedHealth Group.

ELV Elevance Health Financials in INR & Dollars

Revenue

Profit

Cash Flow

Annually

Quarterly

	FY19	Y/Y Change
Revenue	$104.2B	↑ 13.15%
Net Income	$4.8B	↑ 28.19%
Net Profit Margin	4.61%	↑ 0.54%

	FY20	Y/Y Change
Revenue	$121.9B	↑ 16.94%
Net Income	$4.6B	↓ 4.89%
Net Profit Margin	3.75%	↓ 0.86%

	FY21	Y/Y Change
Revenue	$138.6B	↑ 13.76%
Net Income	$6.1B	↑ 33.51%
Net Profit Margin	4.4%	↑ 0.65%

	FY22	Y/Y Change
Revenue	$156.6B	↑ 12.95%
Net Income	$5.9B	↓ 3.44%
Net Profit Margin	3.76%	↓ 0.64%

	FY23	Y/Y Change
Revenue	$171.3B	↑ 9.42%
Net Income	$6.0B	↑ 1.58%
Net Profit Margin	3.49%	↓ 0.27%

	FY24	Y/Y Change
Revenue	$176.8B	↑ 3.19%
Net Income	$6.0B	↓ 0.12%
Net Profit Margin	3.38%	↓ 0.11%

	Q3 FY23	Q/Q Change
Revenue	$42.8B	↓ 1.88%
Net Income	$1.3B	↓ 30.44%
Net Profit Margin	3.01%	↓ 1.23%

	Q4 FY23	Q/Q Change
Revenue	$42.6B	↓ 0.47%
Net Income	$856.0M	↓ 33.59%
Net Profit Margin	2.01%	↓ 1.0%

	Q1 FY24	Q/Q Change
Revenue	$42.6B	↓ 0.16%
Net Income	$2.2B	↑ 162.38%
Net Profit Margin	5.28%	↑ 3.27%

	Q2 FY24	Q/Q Change
Revenue	$43.6B	↑ 2.51%
Net Income	$2.3B	↑ 2.4%
Net Profit Margin	5.27%	↓ 0.01%

	Q3 FY24	Q/Q Change
Revenue	$45.1B	↑ 3.43%
Net Income	$1.0B	↓ 55.83%
Net Profit Margin	2.25%	↓ 3.02%

	Q4 FY24	Q/Q Change
Revenue	$45.4B	↑ 0.66%
Net Income	$418.0M	↓ 58.86%
Net Profit Margin	0.92%	↓ 1.33%

	FY19	Y/Y Change
Profit	$102.2B	↑ 10.98%

	FY20	Y/Y Change
Profit	$33.8B	↓ 66.91%

	FY21	Y/Y Change
Profit	$36.0B	↑ 6.42%

	FY22	Y/Y Change
Profit	$40.0B	↑ 11.0%

	FY23	Y/Y Change
Profit	$47.0B	↑ 17.66%

	FY24	Y/Y Change
Profit	$157.1B	↑ 234.1%

	Q3 FY23	Q/Q Change
Profit	$38.2B	↓ 2.91%

	Q4 FY23	Q/Q Change
Profit	$11.3B	↓ 70.39%

	Q1 FY24	Q/Q Change
Profit	$12.0B	↑ 6.35%

	Q2 FY24	Q/Q Change
Profit	$13.1B	↑ 8.67%

	Q3 FY24	Q/Q Change
Profit	$12.2B	↓ 6.72%

	Q4 FY24	Q/Q Change
Profit	$45.4B	↑ 272.6%

	FY19	Y/Y Change
Operating Cash Flow	$6.1B	↑ 58.37%
Investing Cash Flow	$-2.8B	↑ 121.76%
Financing Cash Flow	$-2.3B	↑ 1.12%

	FY20	Y/Y Change
Operating Cash Flow	$10.7B	↑ 76.34%
Investing Cash Flow	$-7.3B	↑ 162.32%
Financing Cash Flow	$-2.6B	↑ 13.28%

	FY21	Y/Y Change
Operating Cash Flow	$8.4B	↓ 21.74%
Investing Cash Flow	$-9.6B	↑ 31.59%
Financing Cash Flow	$423.0M	↓ 116.48%

	FY22	Y/Y Change
Operating Cash Flow	$8.4B	↑ 0.42%
Investing Cash Flow	$-4.6B	↓ 52.69%
Financing Cash Flow	$-1.3B	↓ 411.58%

Elevance Health Technicals Summary

Sell

Neutral

Buy

Elevance Health is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Elevance Health (ELV) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Elevance Health, Inc	8.91%	-12.07%	-13.22%	-12.55%	91.69%
Cvs Health Corporation	5.87%	5.25%	-8.01%	-31.65%	20.92%
The Cigna Corp	7.17%	-3.13%	-8.15%	35.05%	90.79%
Humana Inc.	0.75%	10.29%	-14.61%	-40.27%	-19.16%
Unitedhealth Group Incorporated	10.22%	-11.52%	14.88%	1.04%	110.65%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Elevance Health, Inc	16.84	16.84	0.77	34.53	0.15	0.05	0.02	181.62
Cvs Health Corporation	18.57	18.57	0.7	5.9	0.06	0.02	0.04	59.97
The Cigna Corp	27.33	27.33	1.0	29.72	0.09	0.04	0.02	149.87
Humana Inc.	26.63	26.63	1.58	16.38	0.07	0.04	0.01	135.73
Unitedhealth Group Incorporated	33.75	33.75	0.93	29.74	0.15	0.07	0.02	101.27

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Elevance Health, Inc	Buy	$98.0B	91.69%	16.84	3.38%
Cvs Health Corporation	Buy	$85.7B	20.92%	18.57	1.25%
The Cigna Corp	Buy	$89.7B	90.79%	27.33	1.39%
Humana Inc.	Buy	$32.1B	-19.16%	26.63	1.02%
Unitedhealth Group Incorporated	Buy	$478.5B	110.65%	33.75	3.6%

Elevance Health Dividend announcements

Elevance Health Dividends March, 2025
In the quarter ending March,2025. Elevance Health has declared dividend of $1.71

About Elevance Health

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. It also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, the company provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. It provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

Organization	Elevance Health
Employees	104200
CEO	Ms. Gail Koziara Boudreaux
Industry	Healthcare

Management People of Elevance Health

Name	Title
Ms. Gail Koziara Boudreaux	President, CEO & Director
Mr. Mark Bradley Kaye	Executive VP & CFO
Ms. Felicia Farr Norwood	Executive VP & President of Government Health Benefits
Mr. Scott Wayne Anglin	SVP, Treasurer & Chief Investment Officer
Mr. Ronald William Penczek	Senior VP, Controller & Chief Accounting Officer
Mr. Scott William Towers	President of Dental Business
Chris Rigg	SVP & CFO of Anthem's Commercial and Specialty Business Division
Dr. Udi Manber Ph.D.	Chief Artificial Intelligence Officer
Ms. Beth Keyser Chesmha	President of Anthem Blue Cross & Blue Shield in Indiana
Dr. Shantanu Agrawal M.D.	Chief Health Officer

Important FAQs about investing in ELV Stock from India :

What is Elevance Health share price today?

Elevance Health share price today stands at $452.69, Open: $430.15 ; Previous Close: $429.33 ; High: $454.24 ; Low: $434.93 ; 52 Week High: $567.26 ; 52 Week Low: $362.21.

The stock opens at $430.15, after a previous close of $429.33. The stock reached a daily high of $454.24 and a low of $434.93, with a 52-week high of $567.26 and a 52-week low of $362.21.

Can Indians buy Elevance Health shares?

Yes, Indians can invest in the Elevance Health (ELV) from India.

With INDmoney, you can buy Elevance Health at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Elevance Health at zero transaction cost.

How can I buy Elevance Health shares from India?

It is very easy to buy Elevance Health from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Elevance Health (ELV) be purchased?

Yes, you can buy fractional shares of Elevance Health with INDmoney app.

What are the documents required to start investing in Elevance Health stocks?

To start investing in Elevance Health, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.